Valneva

  • Valneva aquired Crucell Sweden and DUKORAL from J&J to complement their portfolio of traveler's vaccines
  • The €45m fully underwritten rights issue allows for certainty of funds at time of signing
  • Kempen & Co acted as Joint Global Coordinator and Joint Bookrunner